Listening to Calming Music

NCT06710886 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-03-10

No results posted yet for this study

Summary

The goal of this clinical trial is to explore possible benefits and mechanisms through which listening to music can improve health and wellness. The main goals of the study are:

* To investigate whether pre-survey measures of autonomic reactivity relate to the overall functioning of participants.
* To examine the immediate effects of listening to the augmented music.
* To identify individual characteristics that influence the immediate effects of listening to the augmented music.

Participants will:

PHASE 1:

* Complete the online pre- and post-surveys
* Listen to the brief music demo
* Listen to the full 15-minutes music session

PHASE 2:

* Complete the online pre- and post-surveys.
* Heart rate data will be collected continuously for about 25 minutes. It will be collected for 5 minutes before and after the intervention, and for 15 minutes during the intervention.
* Provide pre- and post- music saliva samples (1.5mL).
* Listen to full 15-minutes music session.

Conditions

  • Music
  • Autonomic State

Interventions

BEHAVIORAL

Augmented Theme

The music is augmented by embedding the natural rhythms of bodily functions (e.g. breathing, heart rate variability, vascular tone, etc) that signal the body to calm.

BEHAVIORAL

Mahler Theme

15-minutes of a Mahler composition.

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Lourdes P Dale, PhD · University of Florida

  • John P Williamson, PhD · University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-04
Primary Completion
2026-07-04
Completion
2026-12-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06710886 on ClinicalTrials.gov